arsenic has been researched along with antimony potassium tartrate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Götz, F; Peschel, A; Rosenstein, R; Wieland, B | 1 |
| Akiyama, S; Chen, ZS; Furukawa, T; Haraguchi, M; Mutoh, M; Sumizawa, T; Tani, A | 1 |
| Baum, C; Bertola, A; Fodstad, O; Lorico, A; Rappa, G | 1 |
| Fardel, O; Lagadic-Gossmann, D; Lecureur, V | 1 |
| Garnier-Suillerot, A; Petroutsa, M; Salerno, M | 1 |
| Amiot, L; Bernard, M; Drenou, B; Fardel, O; Fauchet, R; Lamy, T; Le Meur, A; Le Thiec, A; Lecureur, V | 1 |
6 other study(ies) available for arsenic and antimony potassium tartrate
| Article | Year |
|---|---|
Expression and regulation of the antimonite, arsenite, and arsenate resistance operon of Staphylococcus xylosus plasmid pSX267.
Topics: Adenosine Triphosphatases; Amino Acid Sequence; Antimony; Antimony Potassium Tartrate; Arsenates; Arsenic; Arsenite Transporting ATPases; Arsenites; Bacillus subtilis; Bacterial Proteins; Base Sequence; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Ion Pumps; Lipase; Molecular Sequence Data; Multienzyme Complexes; Operon; Promoter Regions, Genetic; Protein Conformation; R Factors; Staphylococcus; Trans-Activators; Transcription, Genetic | 1992 |
Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cells.
Topics: Adenosine Triphosphate; Antimony; Antimony Potassium Tartrate; Arsenic; ATP-Binding Cassette Transporters; Buthionine Sulfoximine; Cyclic P-Oxides; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glutamate-Cysteine Ligase; Glutathione; Glutathione Transferase; Humans; KB Cells; Metals, Heavy; Multidrug Resistance-Associated Proteins; Nicotinic Acids | 1997 |
Role of the Multidrug Resistance Protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice.
Topics: Animals; Antimony Potassium Tartrate; Arsenic; Arsenites; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Dose-Response Relationship, Drug; Drug Resistance; Genetic Vectors; Glutathione; Humans; Metals, Heavy; Mice; Mice, Knockout; Retroviridae; Sodium Compounds; Survival Analysis; Tumor Cells, Cultured | 2002 |
Potassium antimonyl tartrate induces reactive oxygen species-related apoptosis in human myeloid leukemic HL60 cells.
Topics: Antimony Potassium Tartrate; Apoptosis; Arsenic; Caspases; Cell Division; Cell Survival; Flow Cytometry; HL-60 Cells; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; K562 Cells; Membrane Potentials; Mitochondria; Reactive Oxygen Species; Schistosomicides; Time Factors; Tumor Cells, Cultured; U937 Cells | 2002 |
The MRP1-mediated effluxes of arsenic and antimony do not require arsenic-glutathione and antimony-glutathione complex formation.
Topics: Antimony; Antimony Potassium Tartrate; Arsenic; Arsenic Trioxide; Arsenicals; Biological Transport, Active; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glutathione; Humans; K562 Cells; Kinetics; Leukemia, Promyelocytic, Acute; Multidrug Resistance-Associated Proteins; Oxides; Spectrophotometry, Atomic; Tumor Cells, Cultured | 2002 |
Potassium antimonyl tartrate induces caspase- and reactive oxygen species-dependent apoptosis in lymphoid tumoral cells.
Topics: Amino Acid Chloromethyl Ketones; Antimony Potassium Tartrate; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Caspases; Cell Survival; Coumarins; Cysteine Proteinase Inhibitors; Fluorescent Dyes; Humans; Lymphoma; Oligopeptides; Oxides; Reactive Oxygen Species; Tumor Cells, Cultured | 2002 |